ABERNETHY MATT 4
4 · NEUROCRINE BIOSCIENCES INC · Filed Mar 5, 2026
Insider Transaction Report
Form 4
ABERNETHY MATT
Chief Financial Officer
Transactions
- Gift
Common Stock
[F1][F2]2026-03-04−2,249→ 42,808 total
Footnotes (2)
- [F1]This transaction represents a gift/charitable contribution effective March 4, 2026. This is not a market transaction, thus no price has been reported. No value was received for the gifted shares.
- [F2]Includes an aggregate of 176 shares purchased on February 27, 2026 from the Neurocrine Biosciences, Inc. 2018 Employee Stock Purchase Plan.
Signature
/s/ Darin Lippoldt, Attorney-in-Fact|2026-03-05